Linden Thomas Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Linden Thomas Advisory Services's EW Position: Q3 2026 in Review
Linden Thomas Advisory Services reduced its Edwards Lifesciences (EW) stake by 1.2% in Q3 2026, selling an estimated $11.8K and leaving 10,997 shares worth $949K. The position accounts for 0.08% of the portfolio, ranked #354.
Linden Thomas Advisory Services first reported a position in EW in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.36M in Q2 2023. 430 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Linden Thomas Advisory Services held 10,997 shares of Edwards Lifesciences worth $949K as of Q3 2026.
- Linden Thomas Advisory Services sold 133 Edwards Lifesciences shares in Q3 2026, an estimated $11.8K.
- Edwards Lifesciences made up 0.08% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #354 holding.
- Linden Thomas Advisory Services first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 16 quarters since.
- Linden Thomas Advisory Services's Edwards Lifesciences position peaked at $1.36M in Q2 2023.
- 430 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.